Top news
Patent expires - Ozempic price may be pressured
After a turbulent year, new challenges await pharmaceutical giant Novo Nordisk. Competitors are poised to capitalize as the patent on its best-selling drug expires in several markets.
BusinessAfter a turbulent year, new challenges await pharmaceutical giant Novo Nordisk. Competitors are poised to capitalize as the patent on its best-selling drug expires in several markets.
BusinessYou're up to date in Mattias Arvidsson
That's every story in Mattias Arvidsson for now.